Results 221 to 230 of about 77,443 (276)

A second guanyl nucleotide-binding site associated with adenylate cyclase. Distinct nucleotides activate adenylate cyclase and permit ADP-ribosylation by cholera toxin.

, 1983
D. Michael Gill, Roberta Meren
openalex   +1 more source

The expression of biologically active cholera toxin inEscherichia coli

, 1982
Maria Laura Gennaro, Peter Greenaway, David Broadbent   +2 more
openalex   +2 more sources

Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway [version 1; referees: 2 approved, 2 approved with reservations] [PDF]

, 2016
et al,, Ory, Daniel S
core   +1 more source

Differential binding kinetics of cholera toxin to intestinal microvillus membrane during development

, 1987
Wayne I. Lencer, Su H. Chu, W. Allan Walker   +2 more
openalex   +1 more source

Adenylate Cyclase Activation by Cholera Toxin in Pig Epidermis: An Obligatory Role of the GTP-Regulatory Protein

, 1983
Junji Takeda, Kenji Adachi, Kenneth M. Halprin, Victor Levine, Clyde Woodyard   +4 more
openalex   +1 more source

Design and computational analysis of an effective multi-epitope vaccine candidate using subunit B of cholera toxin as a build-in adjuvant against urinary tract infections. [PDF]

Bioimpacts
Rezaei M, Habibi M, Ehsani P, Asadi Karam MR, Bouzari S.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vibrio cholerae: Cholera toxin

The International Journal of Biochemistry & Cell Biology, 2007
The bacterial protein toxin of Vibrio cholerae, cholera toxin, is a major agent involved in severe diarrhoeal disease. Cholera toxin is a member of the AB toxin family and is composed of a catalytically active heterodimeric A-subunit linked with a homopentameric B-subunit.
vanden Broeck, Davy, Horvath, Caroline A.J., de Wolf, Marc   +2 more
openaire   +4 more sources

Crystalline Cholera Toxin and Toxoid [PDF]

Science, 1972
The exo-enterotoxin of Vibrio cholerae has been obtained in crystalline form. A solution of the crystalline protein was equal in potency to the parent pure toxin in both choleragenicity and skin reactivity. Crystals of the natural toxoid, choleragenoid, resemble those of the toxin in appearance.
Richard A. Finkelstein, Joseph LoSpalluto   +1 more
openaire   +2 more sources

Preclinical pharmacology of cholera toxin

Cancer Chemotherapy and Pharmacology, 1995
Cholera toxin was selected for pharmacologic evaluation by the National Cancer Institute on the basis of antiproliferative activity against small-cell and non-small-cell lung-cancer cell lines. A feature common to the sensitive cell lines was abundant expression of GM1 ganglioside, the cellular receptor for cholera toxin.
John W. Benson, Joel M. Reid, Jean Viallet, Matthew M. Ames   +3 more
openaire   +3 more sources

Deactivation of Cholera Toxin by Ganglioside

Journal of Infectious Diseases, 1971
cholerae leads to the profuse secretory activity seen in choleraic diarrhea. Lipidcontaining extracts of various tissues were found to inhibit the activity of cholera toxin; the highest amounts of the inhibitory factor were found in brain. The inhibitor has properties similar to those of gangliosides.
Nathaniel F. Pierce, William E. van Heyningen, Charles C. J. Carpenter, William B. Greenough   +3 more
openaire   +3 more sources